22174 The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
The past decade has seen new insights into the cytogenetics, molecular genetics, and disease biology of myelofibrosis (MF), including the approval of first- and second-generation JAK inhibitors and newer evidence on using JAK inhibitors in conjunction with hematopoietic stem cell transplantation
Category
Format
  • Online (archived)
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
22132 Overcoming the Challenges of Acute and Chronic GVHD: Learning Workshop on the Integration of Novel Therapies into Modern Management Protocols
Recent clinical developments have transformed the management of graft-versus-host disease (GVHD) and have the potential to increase access to transplants and improve post-HCT outcomes.
Category
Format
  • Online (archived)
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Updates in Lung Cancer Management
This one day symposium will raise and address challenging questions in current clinical practice for thoracic oncology.
Category
Format
Credits
Event date August 20, 2022

Pages